203 Shares in UnitedHealth Group Incorporated (NYSE:UNH) Acquired by Reston Wealth Management LLC

Reston Wealth Management LLC bought a new position in UnitedHealth Group Incorporated (NYSE:UNH) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 203 shares of the healthcare conglomerate’s stock, valued at approximately $119,000.

Several other institutional investors also recently bought and sold shares of UNH. Kathleen S. Wright Associates Inc. bought a new position in UnitedHealth Group during the third quarter valued at approximately $27,000. Global Wealth Strategies & Associates boosted its position in shares of UnitedHealth Group by 152.4% during the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after acquiring an additional 32 shares during the last quarter. Macroview Investment Management LLC raised its stake in UnitedHealth Group by 671.4% during the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after purchasing an additional 47 shares in the last quarter. West Financial Advisors LLC purchased a new position in shares of UnitedHealth Group in the 3rd quarter worth $32,000. Finally, Delos Wealth Advisors LLC raised its position in shares of UnitedHealth Group by 757.1% during the 1st quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock valued at $30,000 after buying an additional 53 shares in the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $564.40 on Friday. The company’s 50 day moving average is $582.30 and its 200 day moving average is $540.65. The company has a quick ratio of 0.88, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm has a market cap of $521.18 billion, a price-to-earnings ratio of 36.77, a PEG ratio of 1.65 and a beta of 0.58. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $608.63.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. The company had revenue of $100.82 billion for the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The firm’s revenue for the quarter was up 9.2% compared to the same quarter last year. During the same quarter last year, the company earned $6.56 earnings per share. On average, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.49%. The ex-dividend date was Monday, September 16th. UnitedHealth Group’s payout ratio is presently 54.72%.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on UNH. Jefferies Financial Group upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and upped their price objective for the company from $481.00 to $647.00 in a research report on Wednesday, July 17th. Stephens dropped their price objective on shares of UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating for the company in a research note on Wednesday, October 16th. Morgan Stanley lowered their target price on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a report on Wednesday, October 16th. KeyCorp assumed coverage on shares of UnitedHealth Group in a research report on Friday, October 11th. They issued an “overweight” rating and a $675.00 price objective on the stock. Finally, Truist Financial reaffirmed a “buy” rating and set a $625.00 target price (down previously from $640.00) on shares of UnitedHealth Group in a research note on Wednesday, October 16th. Four analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $615.53.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.